Home Amines 801312-28-7
801312-28-7,MFCD18206923
Catalog No.:AA00G3LO

801312-28-7 | 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$38.00   $26.00
- +
5mg
≥98%
in stock  
$138.00   $96.00
- +
10mg
≥98%
in stock  
$256.00   $179.00
- +
25mg
≥98%
in stock  
$548.00   $383.00
- +
100mg
≥98%
in stock  
$1,700.00   $1,190.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00G3LO
Chemical Name:
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
CAS Number:
801312-28-7
Molecular Formula:
C27H26N4O5S
Molecular Weight:
518.5841
MDL Number:
MFCD18206923
SMILES:
COc1cccc(c1)N=c1c(c[nH]c2c1cc(cc2C)S(=O)(=O)c1cccc(c1)C(=O)N(C)C)C(=O)N
Properties
Computed Properties
 
Complexity:
922  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
37  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
7  
XLogP3:
3.8  

Literature

Title: Tralau-Stewart CJ, et al. GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization. J Pharmacol Exp Ther, 2011, 337(1), 145-154.

Title: Nials AT, et al. In vivo characterization of GSK256066, a high-affinity inhaled phosphodiesterase 4 inhibitor. J Pharmacol Exp Ther, 2011, 337(1), 137-144.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 801312-28-7
Tags:801312-28-7 Molecular Formula|801312-28-7 MDL|801312-28-7 SMILES|801312-28-7 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide